← Back
$UTHR All transactions

UNITED THERAPEUTICS Corp

M 10b5-1 Plan

$ Value

$481K

Shares

4,000

Price

$120

Filed

Nov 21

Insider

Name

ROTHBLATT MARTINE A

Title

Chairperson & CEO

CIK

0001106578

Roles

Director Officer

Transaction Details

Transaction Date

2025-11-21

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

4,130

Footnotes

This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on May 2, 2025. This plan will continue until the earlier of: (a) exhaustion of a tranche of 294,000 stock options that expire March 15, 2026; or (b) December 31, 2025. | Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke. | This transaction was executed in multiple trades at prices ranging from $476.74 to $477.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $477.77 to $478.675. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $480.18 to $480.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $472.95 to $473.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $475.02 to $476.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries. | Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke. | Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.

Filing Info

Accession No.

0001106578-25-000033

Form Type

4

Issuer CIK

0001082554

ROTHBLATT MARTINE A's History

Date Ticker Type Value
2026-04-22 UTHR M $1.4M
2026-04-22 UTHR $299K
2026-04-22 UTHR $944K
2026-04-22 UTHR $423K
2026-04-22 UTHR $812K
2026-04-22 UTHR $985K
2026-04-22 UTHR $1.0M
2026-04-22 UTHR $636K
2026-04-22 UTHR $348K
2026-04-22 UTHR M $0

Other Insiders at UTHR (90d)

Insider Bought Sold Last
ROTHBLATT MARTINE A
Chairperson & CEO
$193.8M 2026-04-22
KURZWEIL RAY $2.4M 2026-03-04
PATUSKY CHRISTOPHER $579K 2026-04-17
MAHON PAUL A
EVP & GENERAL COUNSEL
$25.9M 2026-04-16
CAUSEY CHRISTOPHER $1.3M 2026-03-30
Thompson Tommy G $2.1M 2026-03-26
Olian Judy D. $417K 2026-03-23
EDGEMOND JAMES
CFO AND TREASURER
$50.8M 2026-04-20
BENKOWITZ MICHAEL
PRESIDENT AND COO
$60.0M 2026-03-15
MALCOLM JAN $97K 2026-03-17